PMV Pharmaceuticals (PMVP)

• Market cap: $63.9M
• 1 day: -1.67%
• 5 days: -5.6%
• 1 month: -16.9%
• 3 months: -1.67%
• 6 months: 10.28%
• Year to date: -22.88%
• 1 year: -24.36%
• 5 years: -97.37%
• 10 years: -96.85%
• Sector: Healthcare
• Industry: Biotechnology

About: PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.

Employees: 47